BIOMAT Database Logo BIOMAT Database Logo

Studies on the biochemical basis for the antiviral activities of some nucleoside analogs. 1975

L L Bennett, and W M Shannon, and P W Allan, and G Arnett

UI MeSH Term Description Entries
D007042 Hypoxanthines Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006564 Herpesviridae A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE. Mouse Thymic Virus,Murid herpesvirus 3,Thymic Group Viruses,Herpesviruses,Mouse Thymic Viruses,Thymic Virus, Mouse,Thymic Viruses, Mouse
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

L L Bennett, and W M Shannon, and P W Allan, and G Arnett
Antiviral nucleoside analogs.
January 2021, Chemistry of heterocyclic compounds,
L L Bennett, and W M Shannon, and P W Allan, and G Arnett
Pharmacological and clinical studies of some nucleoside analogs.
August 1975, Annals of the New York Academy of Sciences,
L L Bennett, and W M Shannon, and P W Allan, and G Arnett
Nucleoside analogs with antiviral activity.
June 1976, Biochemical pharmacology,
L L Bennett, and W M Shannon, and P W Allan, and G Arnett
Antiviral nucleoside analogs phosphorylation by nucleoside diphosphate kinase.
May 2004, Mini reviews in medicinal chemistry,
L L Bennett, and W M Shannon, and P W Allan, and G Arnett
Antiviral activities of pyrimidine nucleoside analogues: some structure--activity relationships.
August 1990, Acta virologica,
L L Bennett, and W M Shannon, and P W Allan, and G Arnett
Biochemical studies on the antiviral activities of the isatin-beta-thiosemicarbazones.
July 1965, Annals of the New York Academy of Sciences,
L L Bennett, and W M Shannon, and P W Allan, and G Arnett
Antiviral therapy: nucleotide and nucleoside analogs.
May 2004, Clinics in liver disease,
L L Bennett, and W M Shannon, and P W Allan, and G Arnett
Basis for clinical resistance to antitumor nucleoside analogs.
August 1975, Annals of the New York Academy of Sciences,
L L Bennett, and W M Shannon, and P W Allan, and G Arnett
Improving nucleoside diphosphate kinase for antiviral nucleotide analogs activation.
October 2002, The Journal of biological chemistry,
L L Bennett, and W M Shannon, and P W Allan, and G Arnett
[Molecular mechanisms of the antiviral activity of nucleoside analogs].
January 1987, Molekuliarnaia genetika, mikrobiologiia i virusologiia,
Copied contents to your clipboard!